Ryan D. Maynard

2011

In 2011, Ryan D. Maynard earned a total compensation of $982.1K as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 44% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$247,200
Option Awards$322,082
Salary$412,000
Other$780
Total$982,062

Maynard received $412K in salary, accounting for 42% of the total pay in 2011.

Maynard also received $247.2K in non-equity incentive plan, $322.1K in option awards and $780 in other compensation.

Rankings

In 2011, Ryan D. Maynard's compensation ranked 5,719th out of 10,747 executives tracked by ExecPay. In other words, Maynard earned more than 46.8% of executives.

ClassificationRankingPercentile
All
5,719
out of 10,747
47th
Division
Manufacturing
2,074
out of 3,960
48th
Major group
Chemicals And Allied Products
457
out of 1,038
56th
Industry group
Drugs
289
out of 786
63rd
Industry
Pharmaceutical Preparations
227
out of 571
60th
Source: SEC filing on April 8, 2014.

Maynard's colleagues

We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2011.

2011

James Gower

Rigel Pharmaceuticals

Chief Executive Officer

2011

Raul Rodriguez

Rigel Pharmaceuticals

Chief Operating Officer

2011

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, President of Discovery and Research

2011

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

You may also like